• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

检测对左氧氟沙星敏感和耐药的葡萄球菌无关菌株中gyrA和grlA突变的快速方法。

Rapid method for detection of gyrA and grlA mutations in unrelated strains of Staphylococci susceptible and resistant to levofloxacin.

作者信息

Messina C, Cafiso V, Campanile F, Santagati M, Stefani S

机构信息

Department of Microbiological and Gynaecological Sciences-University of Catania, Italy.

出版信息

New Microbiol. 2001 Oct;24(4):347-53.

PMID:11718372
Abstract

A panel of 150 clinical isolates of methicillin resistant and susceptible Staphylococci were investigated using a rapid and simple PCR-RFLPs technique to detect DNA nucleotide changes at the site of the most frequently reported mutations in grlA (codons 79, 80) and gyrA (codons 83, 84) genes which confer fluorquinolone resistance in Staphylococci. Convergent dual mutations in and gyrA and grlA were found in all strains exhibiting resistance to ciprofloxacin (MIC, 8 to > or =128 mg/l) and levofloxacin (MIC, 8 to > or =64 mg/l). Mutations in grlA and gyrA were also found in strains susceptible to levofloxacin and resistant to ciprofloxacin. In our sample no strains with only grlA mutations were found. Our data indicate that methicillin-resistant fluorquinolone-resistant strains are likely to have mutations in both grlA and gyrA. In contrast, methicillin-susceptible strains do not show any mutation. The genetic relatedness of a sample of representative epidemiologically unrelated MRSA strains, tested by PFGE and rep-PCR, are in agreement with the hypothesis of a clonal selection of these resistant strains.

摘要

使用一种快速简便的聚合酶链反应-限制性片段长度多态性(PCR-RFLPs)技术,对150株耐甲氧西林和敏感葡萄球菌的临床分离株进行了研究,以检测葡萄球菌中最常报道的赋予氟喹诺酮耐药性的grlA(密码子79、80)和gyrA(密码子83、84)基因位点的DNA核苷酸变化。在所有对环丙沙星(MIC,8至≥128mg/L)和左氧氟沙星(MIC,8至≥64mg/L)耐药的菌株中,均发现了gyrA和grlA中的趋同双突变。在对左氧氟沙星敏感但对环丙沙星耐药的菌株中也发现了grlA和gyrA的突变。在我们的样本中,未发现仅存在grlA突变的菌株。我们的数据表明,耐甲氧西林的氟喹诺酮耐药菌株可能在grlA和gyrA中均有突变。相比之下,甲氧西林敏感菌株未显示任何突变。通过脉冲场凝胶电泳(PFGE)和重复序列聚合酶链反应(rep-PCR)检测的一组具有代表性的、流行病学上无关的耐甲氧西林金黄色葡萄球菌(MRSA)菌株样本的遗传相关性,与这些耐药菌株的克隆选择假说一致。

相似文献

1
Rapid method for detection of gyrA and grlA mutations in unrelated strains of Staphylococci susceptible and resistant to levofloxacin.检测对左氧氟沙星敏感和耐药的葡萄球菌无关菌株中gyrA和grlA突变的快速方法。
New Microbiol. 2001 Oct;24(4):347-53.
2
grlA and gyrA mutations and antimicrobial susceptibility in clinical isolates of ciprofloxacin- methicillin-resistant Staphylococcus aureus.环丙沙星-耐甲氧西林金黄色葡萄球菌临床分离株中的grlA和gyrA突变与抗菌药物敏感性
Eur J Med Res. 2008 Aug 18;13(8):366-70.
3
[In vitro activity of new quinolones against clinical strains of Staphylococcus aureus of the wild type and with mutations characterized by gyrA, gyrB and grlA].新型喹诺酮类药物对野生型及具有gyrA、gyrB和grlA基因突变特征的金黄色葡萄球菌临床菌株的体外活性
Rev Esp Quimioter. 2000 Sep;13(3):271-5.
4
Increased antibacterial activity of DW286, a novel fluoronaphthyridone antibiotic, against Staphylococcus aureus strains with defined mutations in DNA gyrase and topoisomerase IV.新型氟萘啶酮抗生素DW286对DNA旋转酶和拓扑异构酶IV发生特定突变的金黄色葡萄球菌菌株的抗菌活性增强。
Int J Antimicrob Agents. 2005 Apr;25(4):334-7. doi: 10.1016/j.ijantimicag.2004.11.013.
5
Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.曲伐沙星与其他氟喹诺酮类药物对金黄色葡萄球菌纯化的拓扑异构酶以及gyrA和grlA突变体的活性比较。
Antimicrob Agents Chemother. 1999 Aug;43(8):1845-55. doi: 10.1128/AAC.43.8.1845.
6
[A study on the resistance of Staphylococcus aureus and the mechanisms of its resistance to fluoroquinolone].金黄色葡萄球菌对氟喹诺酮类药物的耐药性及其耐药机制研究
Zhonghua Nei Ke Za Zhi. 2001 Mar;40(3):176-9.
7
Susceptibility and resistance genes to fluoroquinolones in methicillin-resistant Staphylococcus aureus isolated in 2002.2002年分离出的耐甲氧西林金黄色葡萄球菌中对氟喹诺酮类药物的敏感和耐药基因
Int J Antimicrob Agents. 2005 May;25(5):374-9. doi: 10.1016/j.ijantimicag.2004.11.016.
8
Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and unrelated strains of methicillin-susceptible and -resistant Staphylococcus aureus.在甲氧西林敏感和耐药金黄色葡萄球菌的流行病学相关及不相关菌株中,不同氟喹诺酮类药物活性与喹诺酮耐药机制存在情况之间的相关性。
Clin Microbiol Infect. 2002 Dec;8(12):781-90. doi: 10.1046/j.1469-0691.2002.00400.x.
9
Evaluation of a high-density oligonucleotide array for characterization of grlA, grlB, gyrA and gyrB mutations in fluoroquinolone resistant Staphylococcus aureus isolates.用于鉴定耐氟喹诺酮金黄色葡萄球菌分离株中grlA、grlB、gyrA和gyrB基因突变的高密度寡核苷酸阵列的评估
J Microbiol Methods. 2005 Feb;60(2):275-9. doi: 10.1016/j.mimet.2004.09.015.
10
Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus.拓扑异构酶IV中的喹诺酮耐药性突变:与flqA位点的关系以及金黄色葡萄球菌中拓扑异构酶IV是氟喹诺酮类药物的主要靶点而DNA回旋酶是次要靶点的遗传学证据。
Antimicrob Agents Chemother. 1996 Aug;40(8):1881-8. doi: 10.1128/AAC.40.8.1881.

引用本文的文献

1
Molecular diagnostics of clinically important staphylococci.临床重要葡萄球菌的分子诊断
Folia Microbiol (Praha). 2004;49(4):353-86. doi: 10.1007/BF03354664.
2
Real-time PCR assay for detection of fluoroquinolone resistance associated with grlA mutations in Staphylococcus aureus.用于检测金黄色葡萄球菌中与grlA突变相关的氟喹诺酮耐药性的实时聚合酶链反应检测法。
J Clin Microbiol. 2003 Jul;41(7):3246-51. doi: 10.1128/JCM.41.7.3246-3251.2003.